Safety and Pharmacokinetics of Dolutegravir in Pregnant HIV Mothers and Their Neonates: A Pilot Study
Phase of Trial: Phase II/III
Latest Information Update: 20 Mar 2017
At a glance
- Drugs Dolutegravir (Primary) ; Efavirenz; Lamivudine; Tenofovir
- Indications HIV infections
- Focus Pharmacokinetics
- 14 Mar 2017 Planned End Date changed from 1 Nov 2016 to 1 Nov 2017.
- 14 Mar 2017 Planned primary completion date changed from 1 Sep 2016 to 1 Sep 2017.
- 14 Mar 2017 Status changed from not yet recruiting to recruiting.